Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R N
RN
Werner
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
A
A
Jacobs
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
S
S
Rosumeck
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R
R
Erdmann
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
B
B
Sporbeck
Division of Evidence Based Medicine (dEBM), Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
A
A
Nast
D000634:Aminoquinolines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017679:Cryotherapy; D003475:Curettage; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004008:Diclofenac / Q000627:therapeutic use; D004224:Diterpenes / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D000077271:Imiquimod; D055623:Keratosis, Actinic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D053685:Laser Therapy; D054020:Lasers, Gas / Q000627:therapeutic use; D010778:Photochemotherapy
C486592:3-ingenyl angelate; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D016861:Cyclooxygenase Inhibitors; D004224:Diterpenes; D004008:Diclofenac; D000077271:Imiquimod; D005472:Fluorouracil